Cargando…

Cardiac Troponin I and Cardiovascular Risk in Patients With Chronic Obstructive Pulmonary Disease

BACKGROUND: Patients with chronic obstructive pulmonary disease (COPD) have increased risk of cardiovascular events. OBJECTIVES: This study evaluated the association between high-sensitivity cardiac troponin I concentration and cardiovascular events in patients with COPD and heightened cardiovascula...

Descripción completa

Detalles Bibliográficos
Autores principales:	Adamson, Philip D., Anderson, Julie A., Brook, Robert D., Calverley, Peter M.A., Celli, Bartolome R., Cowans, Nicholas J., Crim, Courtney, Dixon, Ian J., Martinez, Fernando J., Newby, David E., Vestbo, Jørgen, Yates, Julie C., Mills, Nicholas L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Biomedical 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6119211/ https://www.ncbi.nlm.nih.gov/pubmed/30165984 http://dx.doi.org/10.1016/j.jacc.2018.06.051

Ejemplares similares

Blood pressure, heart rate, and mortality in chronic obstructive pulmonary disease: the SUMMIT trial
por: Byrd, James Brian, et al.
Publicado: (2018)

FEV(1) is a stronger mortality predictor than FVC in patients with moderate COPD and with an increased risk for cardiovascular disease
por: Bikov, Andras, et al.
Publicado: (2020)

Impact of pre-enrolment medication use on clinical outcomes in SUMMIT
por: Vestbo, Jørgen, et al.
Publicado: (2019)

Serum biomarkers and outcomes in patients with moderate COPD: a substudy of the randomised SUMMIT trial
por: Celli, Bartolome R, et al.
Publicado: (2019)

Pharmacotherapy and Lung Function Decline in Patients with Chronic Obstructive Pulmonary Disease. A Systematic Review
por: Celli, Bartolome R., et al.
Publicado: (2021)

International Differences in the Frequency of Chronic Obstructive Pulmonary Disease Exacerbations Reported in Three Clinical Trials
por: Calverley, Peter M. A., et al.
Publicado: (2022)

Cardiovascular outcomes with an inhaled beta2-agonist/corticosteroid in patients with COPD at high cardiovascular risk
por: Brook, Robert D, et al.
Publicado: (2017)

Reply to Fisk and Wilkinson: Aortic Pulse Wave Velocity Predicts All-Cause Mortality in Chronic Obstructive Pulmonary Disease
por: Crim, Courtney, et al.
Publicado: (2020)

Challenging the obesity paradox: extreme obesity and COPD mortality in the SUMMIT trial
por: Brigham, Emily P., et al.
Publicado: (2021)

Association of platelet count with all-cause mortality and risk of cardiovascular and respiratory morbidity in stable COPD
por: Fawzy, Ashraf, et al.
Publicado: (2019)

Adjudication of cardiovascular events in patients with chronic obstructive pulmonary disease: SUMMIT trial
por: Wise, Robert A, et al.
Publicado: (2020)

Efficacy of salmeterol/fluticasone propionate by GOLD stage of chronic obstructive pulmonary disease: analysis from the randomised, placebo-controlled TORCH study
por: Jenkins, Christine R, et al.
Publicado: (2009)

Health status in the TORCH study of COPD: treatment efficacy and other determinants of change
por: Jones, Paul W, et al.
Publicado: (2011)

The severity of airways obstruction as a determinant of treatment response in COPD
por: Calverley, Peter MA, et al.
Publicado: (2006)

Markers of disease activity in COPD: an 8-year mortality study in the ECLIPSE cohort
por: Celli, Bartolome, et al.
Publicado: (2021)

Persistent Systemic Inflammation is Associated with Poor Clinical Outcomes in COPD: A Novel Phenotype
por: Agustí, Alvar, et al.
Publicado: (2012)

Convalescent troponin and cardiovascular death following acute coronary syndrome
por: Adamson, Philip D, et al.
Publicado: (2019)

A Genome-wide analysis of the response to inhaled beta2-agonists in Chronic Obstructive Pulmonary Disease
por: Hardin, Megan, et al.
Publicado: (2015)

Characterisation of COPD heterogeneity in the ECLIPSE cohort
por: Agusti, Alvar, et al.
Publicado: (2010)

High-sensitivity troponin assays and the early rule-out of acute myocardial infarction
por: Shah, Anoop S V, et al.
Publicado: (2013)

High-sensitivity cardiac troponin I assays in the diagnosis of acute myocardial infarction
por: Chapman, Andrew R, et al.
Publicado: (2017)

Variation in Troponin I Measurement and the Cardiovascular Management Approach Following Elevated Troponin I Among Critically Ill Patients With Sepsis
por: Garcia, Michael A., et al.
Publicado: (2023)

Mortality and drug therapy in patients with chronic obstructive pulmonary disease: a network meta-analysis
por: Scott, David A, et al.
Publicado: (2015)

Sensitive Troponin Assay and the Classification of Myocardial Infarction
por: Shah, Anoop S.V., et al.
Publicado: (2015)

Validation of European Society of Cardiology pre-test probabilities for obstructive coronary artery disease in suspected stable angina
por: Bing, Rong, et al.
Publicado: (2020)

Cardiac troponin T and I: back to basics
por: Mingels, Alma M, et al.
Publicado: (2023)

Natural experiments and large databases in respiratory and cardiovascular disease
por: Vestbo, Jørgen
Publicado: (2016)

Sex Differences in Cardiac Troponin I and T and the Prediction of Cardiovascular Events in the General Population
por: Kimenai, Dorien M, et al.
Publicado: (2021)

High-Sensitivity Cardiac Troponin, Statin Therapy, and Risk of Coronary Heart Disease
por: Ford, Ian, et al.
Publicado: (2016)

Fixed Triple Therapy in Chronic Obstructive Pulmonary Disease and Survival. Living Better, Longer, or Both?
por: Vestbo, Jørgen
Publicado: (2020)

Dynamic Changes in High-Sensitivity Cardiac Troponin I in Response to Anthracycline-Based Chemotherapy
por: Tzolos, E., et al.
Publicado: (2020)

High-Sensitivity Cardiac Troponin and the Universal Definition of Myocardial Infarction
por: Chapman, Andrew R., et al.
Publicado: (2020)

How is cardiac troponin released from cardiomyocytes?( )
por: Hammarsten, Ola, et al.
Publicado: (2022)

How to use cardiac troponin in non-cardiac surgery
por: Puelacher, Christian, et al.
Publicado: (2023)

Patient selection for high sensitivity cardiac troponin testing and diagnosis of myocardial infarction: prospective cohort study
por: Shah, Anoop S V, et al.
Publicado: (2017)

From Laënnec’s Stethoscope to the Magic of Imaging, Big Data and Artificial Intelligence: A Timeline of Precision Medicine for Patients with Chronic Obstructive Pulmonary Disease
por: Celli, Bartolome
Publicado: (2023)

Factors associated with change in exacerbation frequency in COPD
por: Donaldson, Gavin C, et al.
Publicado: (2013)

Implications of lowering threshold of plasma troponin concentration in diagnosis of myocardial infarction: cohort study
por: Mills, Nicholas L, et al.
Publicado: (2012)

High-sensitivity cardiac troponin I at presentation in patients with suspected acute coronary syndrome: a cohort study
por: Shah, Anoop S V, et al.
Publicado: (2015)

Mortality after admission with pneumonia is higher than after admission with an exacerbation of COPD
por: Vestbo, Jørgen, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_jd067cs9sa8k2ele1ljs6gpf6q